Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
635 A phase 1, first in human (FIH) study of autologous macrophages engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants (pts) with HER2 overexpressing solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
